EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus

Kuo-Cheng Chang, Yen-Wei Pai, Ching-Heng Lin, I-Te Lee, Ming-Hong Chang iD

PLOS ONE · 15.06.2023 · 18 (6) · e0287373

DOI: 10.1371/journal.pone.0287373 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS ONE, online erschienen am 15.06.2023. Verfasst von Kuo-Cheng Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Neuropathies, Hyperlipidemias. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taichung Veterans General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Previous studies showed conflicting relationship between hyperlipidemia, lipid-lowering therapy and diabetic peripheral neuropathy (DPN). As most of these works emerges from the Western and Australian countries, our study aims to investigate whether hyperlipidemia or lipid-lowering therapy (LLT) is associated with DPN in Taiwanese patients with type 2 diabetes (T2D).

Methods

A cross-sectional, hospital-based observation study in adults with T2D was conducted from January to October 2013. DPN was screened using the Michigan Neuropathy Screening Instrument. Data were obtained at the time of enrollment, including medication usage, anthropometric measurements and laboratory examinations.

Results

2,448 participants were enrolled, 524 (21.4%) of whom had DPN. Patients with DPN had significantly lower plasma total cholesterol (185.6 ± 38.6 vs 193.4 ± 42.3 mg/dL) and low-density lipoprotein cholesterol levels (114.6 ± 32.7 vs 119 ± 30.8 mg/dL). Multivariate analysis demonstrated that neither hyperlipidemia (adjusted OR (aOR), 0.81; 95% confidence interval (CI), 0.49–1.34) nor LLT (aOR, 1.10; 95% CI, 0.58–2.09) was associated with DPN. Subgroup analysis revealed that neither total cholesterol (aOR, 0.72; 95% CI, 0.2–2.62), low-density lipoprotein cholesterol levels (aOR, 0.75; 95% CI, 0.2–2.79), statin (aOR, 1.09; 95% CI, 0.59–2.03) nor fibrate (aOR, 1.73; 95% CI, 0.33–1.61) was associated with DPN.

Conclusion

Our results suggest that neither hyperlipidemia nor lipid-lowering medication was associated with DPN in adults with T2D. DPN is a multifactorial disease, and our findings indicate that lipid metabolism may play a minor role in its pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NeuropathiesHyperlipidemiasAdultHumansAustraliaCholesterolCross-Sectional StudiesHypolipidemic AgentsLipidsLipoproteins, LDLRisk Factors

Substanzen

CholesterolHypolipidemic AgentsLipidsLipoproteins, LDL

Autor:innen und Institutionen

  • Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Department of Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

ORCID-Profile: Ming-Hong Chang

Förderung

  • Taichung Veterans General Hospital

Zitieren

APA

Chang, K. C., Pai, Y. W., Lin, C. H., Lee, I. T., & Chang, M. H. (2023). The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. PLOS ONE, 18(6), e0287373. https://doi.org/10.1371/journal.pone.0287373

Vancouver

Chang KC, Pai YW, Lin CH, Lee IT, Chang MH. The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. PLOS ONE. 2023;18(6):e0287373. doi:10.1371/journal.pone.0287373

BibTeX
@article{Chang2023,
  author = {Chang, Kuo-Cheng and Pai, Yen-Wei and Lin, Ching-Heng and Lee, I-Te and Chang, Ming-Hong},
  title = {The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {6},
  pages = {e0287373},
  doi = {10.1371/journal.pone.0287373}
}
Kostenlos starten →